Product Information
AMANTADINE 100 MG TABLET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.3143 per EA under NDC 00832011150. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 16, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the amantadine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832011150
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMANTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076186FDA Approved
12/16/2002
TE Code
AB
On Market Since
12/15/2011
Pharmacological Classes
Price Statistics
The NADAC for AMANTADINE 100 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3143 per EA |
|---|---|
| All-time high | $1.7196 (Jan 14, 2015) |
| All-time low | $0.2949 (Jul 22, 2026) |
| 52-week high | $0.4204 |
| 52-week low | $0.2949 |
| Median price | $0.8611 |
| Average price | $0.9962 |
| Largest weekly change | +46.3% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amantadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amantadine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Influenza A M2 Protein Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMANTADINE 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMANTADINE 100 MG TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.3143 per EA (NDC 00832011150), effective Sep 30, 2026.
How has the price of AMANTADINE 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMANTADINE 100 MG TABLET has declined 79.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMANTADINE 100 MG TABLET?
Since Nov 28, 2013, the NADAC for AMANTADINE 100 MG TABLET has ranged from a low of $0.2949 (Jul 22, 2026) to a high of $1.7196 (Jan 14, 2015), with a median of $0.8611 per EA.
Are there cheaper alternatives to AMANTADINE 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AMANTADINE 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMANTADINE 100 MG TABLET?
AMANTADINE 100 MG TABLET (NDC 00832011150) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.